Search research articles
Contact Us
Filters
Showing results (11-20 of 191) with videos related to
Page
of 20
Sort By:
Cancer Investigation
|
April 9, 2001
Quality improvement efforts in oncology: are we ready to begin?
C L Bennett, J M Crane,
Applied Animal Behaviour Science
|
February 17, 2001
Twenty-four hour activity budgets and patterns of behavior in captive ocelots (Leopardus pardalis)
S H. Weller, C L. Bennett
Cancer Treatment and Research
|
January 29, 2000
Does reimbursement affect physician decision making?
C L Bennett, T J Stinson
Cancer Investigation
|
February 7, 2001
Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial
C L Bennett, T J Stinson
Stem Cells (Dayton, Ohio)
|
May 1, 1996
A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation
I L Westerman, C L Bennett
American Journal of Surgery
|
July 1, 1995
The learning curve for laparoscopic cholecystectomy. The Southern Surgeons Club
M J Moore, C L Bennett
Current Opinion in Pediatrics
|
December 26, 2001
IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena
C L Bennett, H D Ochs
Annals of Internal Medicine
|
February 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease
S C Gulati, C L Bennett
Oncology (Williston Park, N.Y.)
|
November 1, 1995
Economic analysis during phase III clinical trials: who, what, when, where, and why?
C L Bennett, I L Westerman
Clinical Performance and Quality Health Care
|
June 7, 1995
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?
C L Bennett, E Oddone, D Matchar
Page
of 20
Search research articles
Search
Showing results (11-20 of 191) with videos related to
Sort By:
Page
of 20
Cancer Investigation
|
April 9, 2001
Quality improvement efforts in oncology: are we ready to begin?
C L Bennett, J M Crane,
Applied Animal Behaviour Science
|
February 17, 2001
Twenty-four hour activity budgets and patterns of behavior in captive ocelots (Leopardus pardalis)
S H. Weller, C L. Bennett
Cancer Treatment and Research
|
January 29, 2000
Does reimbursement affect physician decision making?
C L Bennett, T J Stinson
Cancer Investigation
|
February 7, 2001
Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial
C L Bennett, T J Stinson
Stem Cells (Dayton, Ohio)
|
May 1, 1996
A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation
I L Westerman, C L Bennett
American Journal of Surgery
|
July 1, 1995
The learning curve for laparoscopic cholecystectomy. The Southern Surgeons Club
M J Moore, C L Bennett
Current Opinion in Pediatrics
|
December 26, 2001
IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena
C L Bennett, H D Ochs
Annals of Internal Medicine
|
February 1, 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease
S C Gulati, C L Bennett
Oncology (Williston Park, N.Y.)
|
November 1, 1995
Economic analysis during phase III clinical trials: who, what, when, where, and why?
C L Bennett, I L Westerman
Clinical Performance and Quality Health Care
|
June 7, 1995
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?
C L Bennett, E Oddone, D Matchar
Page
of 20